Arianna Loregian

Disruption of protein–protein interactions: Towards new targets for chemotherapy

Giorgio Palù, G. Palù, A. Loregian, 2005, Journal of cellular physiology.

Small molecule inhibitors of influenza A and B viruses that act by disrupting subunit interactions of the viral polymerase

Giorgio Palù, Gabriele Cruciani, Laura Goracci, 2012, Proceedings of the National Academy of Sciences.

How academic labs can approach the drug discovery process as a way to synergize with big pharma.

Giorgio Palù, G. Palù, A. Loregian, 2013, Trends in microbiology.

Protein–protein interactions as targets for antiviral chemotherapy

Giorgio Palù, G. Palù, H. Marsden, 2002, Reviews in medical virology.

Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.

Peng Zhan, Xiao Ding, Ye Tian, 2018, Journal of medicinal chemistry.

Optimization of N-Substituted Oseltamivir Derivatives as Potent Inhibitors of Group-1 and -2 Influenza A Neuraminidases, Including a Drug-Resistant Variant.

Peng Zhan, Xiao Ding, Ye Tian, 2018, Journal of medicinal chemistry.